Daniel Zedek, MD

Article

Squamous Cell Carcinoma of the Lip Associated With Adalimumab Therapy for Ankylosing Spondylitis: A Case Report and Review of TNF-α Inhibitors and Cutaneous Carcinoma Risk

Author:

Daniel Zedek, MD

Adalimumab is an anti–tumor necrosis factor α (TNF-α) agent approved for the treatment of ankylosing spondylitis (AS); psoriatic arthritis; an...

• Read More